INSP — Inspire Medical Systems Income Statement
0.000.00%
Last trade - 00:00
- $7.02bn
- $6.56bn
- $624.80m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 82 | 115 | 233 | 408 | 625 |
Cost of Revenue | |||||
Gross Profit | 68.4 | 97.8 | 200 | 342 | 528 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 117 | 172 | 273 | 455 | 665 |
Operating Profit | -34.9 | -56.2 | -39.9 | -47.6 | -40.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -33.2 | -57.1 | -42 | -44.3 | -19.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -33.2 | -57.2 | -42 | -44.9 | -21.2 |
Net Income Before Extraordinary Items | |||||
Net Income | -33.2 | -57.2 | -42 | -44.9 | -21.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -33.2 | -57.2 | -42 | -44.9 | -21.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.4 | -2.19 | -1.54 | -1.6 | -0.722 |